Ophthalmological implant comprising an active ingredient release system and method for producing an ophthalmological implant of this type
AssigneeCarl Zeiss Meditec AG
InventorMichael Thaller
Life of this patent
Estimating the term…
Abstract
Provided are ophthalmological implants comprising an active ingredient release system which, when the ophthalmological implant is implanted, delivers at least one pharmacological active ingredient, the active ingredient release system comprising at least one hydrogel as a matrix, the hydrogel forming a layer on an optical portion of the implant, binding covalently to the optical portion and being charged with the at least one active ingredient. Also provided are methods for producing the ophthalmological implant comprising the active ingredient release system.
Claims14
An ophthalmological implant, comprising:
- at least one hydrogel as a matrix, and
- at least one optical component,
- wherein the at least one hydrogel forms a layer on the optical component of the implant, is covalently bonded to the optical component, and is laden with at least one pharmacologically active ingredient, and
- wherein the at least one pharmacologically active ingredient is released when the ophthalmological implant is implanted into a tissue of a subject.
A process for producing an ophthalmological implant, which comprises:
- providing an active ingredient release system,
- wherein the active ingredient release system releases at least one pharmacologically active ingredient when the ophthalmological implant is implanted into a subject,
- providing an optical component,
- coating the optical component with at least one hydrogel as matrix of the active ingredient release system, and
- covalently binding the at least one hydrogel to the optical component, wherein the at least one hydrogel is laden with the at least one active ingredient.
Dependencies are inferred from the claim text.